aMoon is a global HealthTech and Life Sciences investment fund based in Israel. As Israel’s largest HealthTech fund, with $1.1 billion AUM, we partner with outstanding entrepreneurs who harness groundbreaking science and technology to transform healthcare. Together with our portfolio companies, we work tirelessly to advance solutions that will help people live healthier, better lives. We harness our unique team of over 50 scientists, physicians and entrepreneurs and our global network of investors and industry leaders to build bridges between our portfolio companies and global tech, finance and medical research hubs to help entrepreneurs turn their vision into reality. Through our Velocity Fund we invest in companies pursuing disruptive, cutting-edge technologies as early as venture formation through Series A. Our Growth Fund invests in later-stage companies that are either generating revenue in growth rounds, pre-IPO rounds or in pivotal clinical trials.
38
Total Investments
27
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Biotechnology, Health Care
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About aMoon
Recent Investments (38)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | Oct 2025 | |
| Series A | •••••• | Dec 2024 | |
| Series D | •••••• | Nov 2024 | |
| Series B | •••••• | May 2024 | |
| Series B | •••••• | Nov 2023 | |
|
|
Series C | •••••• | Sep 2023 |
|
|
Series B | •••••• | Aug 2023 |
|
|
Series A | •••••• | Nov 2022 |
|
|
Series A | •••••• | Sep 2022 |
|
|
Series C | •••••• | Aug 2022 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.